CVS Health (NYSE:CVS) Upgraded at Leerink Partnrs
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.23 EPS and FY2028 earnings at $9.36 EPS. CVS has been the topic of a number of […]
Leerink Partnrs upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.23 EPS and FY2028 earnings at $9.36 EPS. CVS has been the topic of a number of […]
